StonvexLoading…
StonvexStonvexStonvexCore line items from IOVA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $263.50M | $164.07M | $1.19M |
Operating Income | $-403.36M | $-395.28M | $-460.56M |
Net Income | $-390.98M | $-372.18M | $-444.04M |
EPS (Diluted) | $-1.09 | $-1.28 | $-1.89 |
Total Assets | $913.17M | $910.43M | $780.35M |
Total Liabilities | $214.59M | $200.02M | $195.74M |
Cash & Equivalents | $163.08M | $115.69M | $114.89M |
Free Cash Flow OCF − CapEx | $-336.24M | $-364.05M | $-384.11M |
Shares Outstanding | 411.94M | 305.25M | 256.14M |